CGAP, Symbiotics Partner to Monitor COVID-19’s Impact on Microfinance

Nov 2020
Global, November, 16 2020 - CGAP and Symbiotics today launched a partnership to track and analyze the performance of hundreds of microfinance institutions (MFIs) across the world over the next six months, in an ongoing effort to shed light on how the COVID-19 pandemic is impacting the microfinance sector.

The COVID-19 pandemic has put the microfinance sector under considerable strain, as economic slowdowns have made it difficult for many borrowers to repay their loans. While CGAP’s earlier research on the crisis helped dispel concerns about an imminent liquidity crisis, there are ongoing concerns about microfinance institutions’ portfolio quality, solvency, and ability to continue serving excluded customers amid pressures of the pandemic.

To help fill the void of publicly available data on how this crisis is playing out, CGAP and Symbiotics – a leading microfinance investment vehicle – will be analyzing data on the performance of the more than 300 MFIs in Symbiotics global portfolio. We will publish our analyses at as a series of brief reports (“snapshots”) that include key indicators on issues such as portfolio quality, moratoria, disbursements, repayments, and solvency, as well as our insights around key developments and what they mean for the future.

“Since March of this year, we have been carefully monitoring the effects of the COVID-19 pandemic on the microfinance sector through key indicators provided on a monthly basis by our partner MFIs,” said Vincent Lehner, head of markets for Symbiotics. “The collaboration with CGAP brings complementary insights into how the sector is doing. We are pleased to see it get public visibility for the benefit of all those interested.”

The CGAP-Symbiotics partnership launches at a time when the CGAP Global Pulse Survey on Microfinance Institutions is entering its final wave and drawing to a close. Begun in June as a short-term solution to the need for data amid a fast-moving crisis, the pulse survey has provided critical information and analysis to funders and policy makers in the early stages of the COVID-19 pandemic.

“The pulse survey was instrumental in quickly providing data and insights on how COVID-19 affected the microfinance sector. In particular, it played a key role in allaying the financial inclusion community’s fears of a catastrophic liquidity crunch among MFIs and refocusing attention on issues related to solvency and lending behavior. As the survey wraps up, this new partnership with Symbiotics will enable us to continue providing valuable data on an ongoing basis and with a focus on longer-term concerns,” said Peter Zetterli, who led the pulse survey effort for CGAP.

The first snapshot in the CGAP-Symbiotics series is now available. Among its findings is that expiring moratoria and deteriorating loan portfolios appear to be leading many MFIs to adopt conservative lending practices. While this may be prudent from a risk management standpoint, it raises concerns about the sector’s ability to continue serving low-income clients during the crisis.

Source : CGAP

Research Analysis Tools

The fund indexes, institution benchmarks and other market information displayed here are all Symbiotics designed analysis tools, created in-house by our analysts and experts. Symbiotics has one of the oldest track records in microfinance investment analysis dating back to the late 1990s; its indexes and benchmarks have been regularly used as markers by investors, asset managers, financial institutions and practitioners. These, as well as several other research products, are available through the Research Account. Click on the link below to find out more.

Learn More